No.

Publication Date

Citing Article

1

2025

Maqbool Ahmed Rahu, Qammaruddin Shaikh, Mussarat Jabeen, Shahida Perveen. Regulation of hyperglycemia in type 2 diabetes mellitus: Insights into current therapeutic pathways, Letters in Drug Design & Discovery. 2025; 22: 100204100204.  https://doi.org/10.1016/j.lddd.2025.100204

2

2026

José Francisco Miranda Bajaña, Byron Andres Chamba Lapo, Kevin Hair Taipe Mayorga, Marilyn Denise Guevara Acurio, Edison Patricio Ninabanda Inca. Actualización del manejo de la cetoacidosis diabética según las guías ADA 2024–2026: una scoping review de la evidencia reciente, Revista Multidisciplinar Epistemología de las Ciencias. 2026; 3: 1115.  https://doi.org/10.71112/70cncx27

3

2026

Dipti Tiwari, Wann Jia Loh, Tar Choon Aw. Paradigm Shifts in Diabetes Management: Key Highlights from the 2026 American Diabetes Association Standards of Care in Diabetes, LabMed. 2026; 3: 10.  https://doi.org/10.3390/labmed3020010

4

2025

Sensuke Konno, Sean Fullerton. Hypoglycemic Effect of Mushroom Extract (SXF) on Type 2 Diabetes Patients and Its Possible Mechanism, Open Journal of Endocrine and Metabolic Diseases. 2025; 15: 161.  https://doi.org/10.4236/ojemd.2025.159016

5

2025

Nahyun Koo, Eun Ji Lee, Ji-Eun Chang, Kyeong-Ryoon Lee, Yoon-Jee Chae. Pharmacokinetic Landscape and Interaction Potential of SGLT2 Inhibitors: Bridging In Vitro Findings and Clinical Implications, Pharmaceutics. 2025; 17: 1604.  https://doi.org/10.3390/pharmaceutics17121604

6

2026

Andra Melissa Entuc, Maria Bogdan, Ianis Kevyn Stefan Boboc, Liliana Mititelu Tartau, Delia Reurean Pintilei, Liliana Lacramioara Pavel, Ana-Maria Pelin, Aurelia Spinei, Liliana Georgeta Foia. Selected Emerging Biomarkers in Type 2 Diabetes Mellitus: Clinical Insights and Implications for Precision Care, Medicina. 2026; 62: 152.  https://doi.org/10.3390/medicina62010152

7

2025

Abdullah AlJedai, Hajar Amin, Fuad Alanazi, Hamood AlSudais, Abdulrahman Alshalani. The Association Between HbA1c Levels And Hematological Biomarkers in Adults with Type 2 Diabetes Mellitus: A Retrospective Study, International Journal of General Medicine. 2025; Volume 18: 7725.  https://doi.org/10.2147/IJGM.S572310

8

2025

Ami Sanghvi, Sona Warrier. Effectiveness and Safety of a Fixed-Dose Combination of Dapagliflozin and Vildagliptin in the Treatment of Type 2 Diabetes Mellitus: A Retrospective Study, Cureus. 2025;   https://doi.org/10.7759/cureus.97192